Abstract
Nature-derived exosomes have been noted as emerging carriers for anticancer drugs. In this study, as a proof-of-concept, the anticancer drug doxorubicin (Dox) was loaded onto i-motif-modified exosomes (Exo-i-motif) to deliver Dox to cancer cells efficiently. The double-stranded biotin-i-motif/flare (ds-i-motif-bio)s efficiently released Dox in an acidic pH-responsive manner within 1 h. Based on gel electrophoresis, it was clearly confirmed that ds-i-motif-bio successfully interacts with biotin-conjugated exosomes and streptavidin (strep) via the biotin–streptavidin interaction. The particle sizes were below 150 nm without aggregation after strep-mediated modification of ds-i-motif-bio on the surfaces of the exosomes. In addition, released Dox had intact bioactivity for anti-proliferation after immobilization onto the exosomes. This study could serve as a new concept of pH-responsive delivery systems of anticancer drug using nature-derived exosomes with i-motifs.
Similar content being viewed by others
References
Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11(6):673–692
Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941–951
Kim J, Lee YM, Kang Y, Kim WJ (2014) Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics. ACS Nano 8(9):9358–9367
Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579
Yu G, Jung H, Kang YY, Mok H (2018) Comparative evaluation of cell- and serum-derived exosomes to deliver immune stimulators to lymph nodes. Biomaterials 162:71–81
Wan S, Zhang L, Wang S, Liu Y, Wu C, Cui C, Sun H, Shi M, Jiang Y, Li L, Qiu L, Tan W (2017) Molecular recognition-based DNA nanoassemblies on the surfaces of nanosized exosomes. J Am Chem Soc 139(15):5289–5292
Tamura R, Uemoto S, Tabata Y (2017) Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater 57:274–284
Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, Huang NP, Xiao ZD, Lu ZH, Tannous BA, Gao J (2018) Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150:137–149
Feng LZ, Dong ZL, Tao DL, Zhang YC, Liu Z (2018) The acidic tumor microenvironment: a target for smart cancer nano-theranostics. Natl Sci Rev 5(2):269–286
Yu X, Yang X, Horte S, Kizhakkedathu JN, Brooks DE (2014) A pH and thermosensitive choline phosphate-based delivery platform targeted to the acidic tumor microenvironment. Biomaterials 35(1):278–286
Danhier F, Feron O, Preat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148(2):135–146
Day HA, Pavlou P, Waller ZA (2014) i-Motif DNA: structure, stability and targeting with ligands. Bioorg Med Chem 22(16):4407–4418
Huang J, He Y, Yang X, Wang K, Ying L, Quan K, Yang Y, Yin B (2014) I-motif-based nano-flares for sensing pH changes in live cells. Chem Commun (Camb) 50(99):15768–15771
Mata G, Luedtke NW (2015) Fluorescent probe for proton-coupled DNA folding revealing slow exchange of i-motif and duplex structures. J Am Chem Soc 137(2):699–707
Sharma J, Chhabra R, Yan H, Liu Y (2007) pH-driven conformational switch of “i-motif’’ DNA for the reversible assembly of gold nanoparticles. Chem Commun 5:477–479
Ying L, Xie N, Yang Y, Yang X, Zhou Q, Yin B, Huang J, Wang K (2016) A cell-surface-anchored ratiometric i-motif sensor for extracellular pH detection. Chem Commun (Camb) 52(50):7818–7821
Liu J, Ma XW, Lei CN, Xue XD, Wei T, Zhao J, Li SY, Liang XJ (2016) A self-assembled DNA nanostructure for targeted and pH-triggered drug delivery to combat doxorubicin resistance. J Mater Chem B 4(22):3854–3858
Song L, Ho VH, Chen C, Yang Z, Liu D, Chen R, Zhou D (2013) Efficient, pH-triggered drug delivery using a pH-responsive DNA-conjugated gold nanoparticle. Adv Healthc Mater 2(2):275–280
Liu M, Chen D, Wang C, Chen X, Wen Z, Cao Y, He H (2015) Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. J Drug Target 23(9):800–805
Kim KY, Kim SH, Yu SN, Park SK, Choi HD, Yu HS, Ji JH, Seo YK, Ahn SC (2015) Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin. Mol Med Rep 12(2):1898–1904
Kim J, Lee E, Kang YY, Mok H (2015) Multivalent aptamer-RNA based fluorescent probes for carrier-free detection of cellular microRNA-34a in mucin1-expressing cancer cells. Chem Commun (Camb) 51(43):9038–9041
Jung H, Mok H (2016) Mixed micelles for targeted and efficient doxorubicin delivery to multidrug-resistant breast cancer cells. Macromol Biosci 16(5):748–758
Yao VJ, D’Angelo S, Butler KS, Theron C, Smith TL, Marchio S, Gelovani JG, Sidman RL, Dobroff AS, Brinker CJ, Bradbury ARM, Arap W, Pasqualini R (2016) Ligand-targeted theranostic nanomedicines against cancer. J Control Release 240:267–286
Jeong H, Lee SH, Hwang Y, Yoo H, Jung H, Kim SH, Mok H (2017) Multivalent aptamer-RNA conjugates for simple and efficient delivery of doxorubicin/siRNA into multidrug-resistant cells. Macromol Biosci 17(4):1600343
Liu F, Zhang JZ, Mei Y (2016) The origin of the cooperativity in the streptavidin–biotin system: a computational investigation through molecular dynamics simulations. Sci Rep 6:27190
Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157–170
Shen F, Chu S, Bence AK, Bailey B, Xue X, Erickson PA, Montrose MH, Beck WT, Erickson LC (2008) Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J Pharmacol Exp Ther 324(1):95–102
Zeng X, Morgenstern R, Nystrom AM (2014) Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance. Biomaterials 35(4):1227–1239
Geisow MJ, Evans WH (1984) pH in the endosome measurements during pinocytosis and receptor-mediated endocytosis. Exp Cell Res 150(1):36–46
Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73(5):1524–1535
Acknowledgments
This study was supported by Konkuk University in 2018.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.Y., Song, J., Jung, H. et al. I-motif-coated exosomes as a pH-sensitive carrier for anticancer drugs. Appl Biol Chem 61, 599–606 (2018). https://doi.org/10.1007/s13765-018-0394-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13765-018-0394-0